Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Condition(s):Glioma; Malignant Glioma of Brain; Recurrence TumorLast Updated:June 15, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Glioma; Malignant Glioma of Brain; Recurrence TumorLast Updated:June 15, 2021Unknown status
Condition(s):Relapsed/Refractory B-cell Non-Hodgkin’s LymphomaLast Updated:April 5, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:December 3, 2020Completed
Condition(s):Lymphoma, Large-Cell, Anaplastic; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell, PeripheralLast Updated:January 18, 2023Completed
Condition(s):Recurrent B-Cell Tumor; Refractory B-Cell TumorLast Updated:January 1, 2016Unknown status
Condition(s):Lymphoma, B-Cell; Lymphoma, Non-hodgkins; Chronic Lymphocytic Leukemia; B-Cell Chronic Lymphocytic LeukemiaLast Updated:February 15, 2022Terminated
Condition(s):B-cell Non Hodgkin LymphomaLast Updated:May 26, 2022Recruiting
Condition(s):Colorectal Cancer; Triple Negative Breast Cancer; Sarcoma; Nasopharyngeal Carcinoma; Prostate Cancer; Gastric CancerLast Updated:September 27, 2019Unknown status
Condition(s):Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma; Large B-cell Lymphoma; Follicular Lymphoma Grade 3A; Follicular Lymphoma Grade 3BLast Updated:January 16, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:December 28, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.